Ashland offers web-based film coatings troubleshooting tool

Published: 31-Oct-2014
Manufacturing Research & Development

To enable formulators to solve their toughest tablet-coating challenges


Formulators are looking for swift, tailored solutions to identify the best film coating for their dosage forms and to respond more quickly to film-coating issues when they arise. To meet this need, Ashland Specialty Ingredients offers a web-based film coatings troubleshooting tool to enable formulators to solve their toughest tablet-coating challenges.

'Film-coating choices directly affect the efficacy of a tablet formulation,' said Stuart Porter, senior research fellow and technical lead, Global Film Coating Technology at Ashland Speciality Ingredients.

'Our new film coating troubleshooting tool presents typical problems experienced during the coating process and insights that can help formulators resolve them. We work closely with customers to enable them to choose the best coating for each formulation. We provide global technical assistance and deliver solutions to meet our customers' product development needs.'

Ashland’s ready-to-use Aquarius film coating systems have a range of functions to suit almost any core.

Our new film coating troubleshooting tool presents typical problems experienced during the coating process

The company's functional coating capabilities, including moisture barrier, odour- and taste-masking, and controlled/delayed release, are based on acrylate polymers or combinations of cellulosic and other polymers and unique ingredients to offer the desired functionality.

'The new website is organised around Ashland’s key applications and products, making it more convenient for formulators to find the information they need and to be able to contact us directly with their questions,' said David Neuberger, Vice President, Ashland Pharmaceutical Ingredients.

Ashland’s tablet film-coating capabilities are underscored by its broad network of technical support and laboratories down to the regional level.

The company operates pharmaceutical centres of excellence in Wilmington, Delaware, US and Hyderabad, India, and regional supporting laboratories in Düsseldorf, Germany; Istanbul, Turkey; São Paulo, Brazil; Buenos Aires, Argentina and Shanghai, China.

  • Companies:
  • Ashland
See more

You may also like

Manufacturing

Ashland announces HPC matrix former for extended-release tablets

Read more
The product is designed help to improve patient compliance with drug regimens at a time when compliance is a major stumbling block for those with chronic disease

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation
  3. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  4. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  5. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Ashland announces HPC matrix former for extended-release tablets

The product is designed help to improve patient compliance with drug regimens at a time when compliance is a major stumbling block for those with chronic disease
Design & Build

Ashland opens pharmaceutical technical centre in Shanghai

Senior leaders showcase a state-of-the-art facility
Design & Build

Ashland opens world-class pharmaceutical excipient production facility in Nanjing, China

Ashland now manufactures its major brands of excipients in Nanjing to better serve China’s burgeoning pharmaceutical industry
Manufacturing

Ashland receives EXCiPACT GMP certification as a supplier of pharmaceutical excipients

The first site in the US to receive EXCiPACT certification, its scope covers the production, testing and packaging of PVP and PVPP
Manufacturing

Ashland opens new drug development centre of excellence in Wilmington, US

Increases its pharmaceutical technologies capabilities to address global drug development and bioavailability enhancement trends
Manufacturing

Ashland to expand capacity for Klucel tablet binding and coating product

To meet growing customer demand in applications for pharmaceuticals and dietary supplements
Manufacturing

Ashland to expand capabilities at Delaware Centre of Excellence

Will relocate spray drying and extrusion processes from Maryland to Delaware
Subscribe now